AstroNova, Inc.

Regulatory Filings • Dec 18, 2003

8-K 1 form8k.htm Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) December 18, 2003 ASTRO-MED, INC (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) COMMISSION FILE NUMBER 0-13200 RHODE ISLAND 05-0318215 (STATE OR OTHER JURISDICTION OF (IRS EMPLOYER IDENTIFICATION INCORPORATION OR ORGANIZATION) NUMBER) 600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE) (401-828-4000) (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE) ITEM 9. Regulation FD Disclosure. On December 17, 2003, Albert W. Ondis, Chief Executive Officer, of Astro-Med, Inc. (ALOT) posted the following remarks regarding the Company's current stock price and the recently issued Provident Equity Research Report on Yahoo's message board. "The current stock price decline is certainly on my mind and I have had lots of phone calls about it. I must say emphatically here that I have no idea why the price has dropped. There is no negative news. " Some people say the decline is due to the move by institutions from small cap issues to large cap. Others say the decline is because we are too conservative to provide EPS and revenue guidance. Others say it is because the float is too small and we should split the stock. Still others say it is because officers are selling thereby demonstrating a lack of confidence. "Let me address some of these. Firstly, the officers who have sold stock continue to own substantial amounts of stock. They are all hard working, fully committed people who believe, as I do, that Astro-Med is a growth company which one day will be a large and important company. Incidentally, the stock they sold (through the execution of options) had the effect of increasing the float. "Secondly, although it is our current policy not to provide guidance we have been saying at our teleconferences that we believe the earnings and revenue trends of the past few quarters will continue. "Our strategy has been simply to perform, not proclaim. Perhaps in the future we will change this policy. Meanwhile, I suggest that interested people review the recent research report issued by Provident Research (www.providentresearch.com). The conclusions are those of the author, but we have no serious argument with them. Wishing all a healthy and prosperous Holiday Season, I am: Albert W. Ondis CEO Astro-Med, Inc (ALOT)" SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized. DATE: December 18, 2003 ASTRO-MED, INC. By: /s/ Joseph P. O'Connell -------------------------- Vice President, Treasurer and Chief Financial Officer